Navigation Links
Generex Biotechnology to Make Presentations At 46th Annual Meeting,of the European Society of Pediatric Endocrinology

the Company's Vice-President for Medical Affairs.

The European Society for Paediatric Endocrinology (ESPE) is an international organization with several hundred members from over 45 countries whose aim is to promote the highest levels of knowledge, research, education, and clinical practice of paediatric endocrinology and metabolism throughout the world. Founded in 1962, ESPE has increased in both size and scope, becoming one of the largest and most leading international scientific communities of paediatric endocrinologists.

About Generex

Generex is engaged in the research and development of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist(tm) device. The Company's flagship product, oral insulin (Generex Oral-lyn(tm)), which is available for sale in Ecuador for the treatment of patients with Type-1 and Type-2 diabetes, is in various stages of clinical trials around the world. For more information, visit the Generex website at http://www.generex.com. Safe Harbor Statement: This release and oral statements made from time to time by Generex representatives concerning the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by introductory words such as "expects," "plans," "intends," "believes," "will," "estimates," "forecasts," "projects" or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing potential product applications
'"/>




Page: 1 2 3

Related medicine technology :

1. Generex Biotechnology Vaccine Strategy Presented at International Conference in London
2. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
3. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
4. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
5. Prana Biotechnology Presents New Key Findings on PBT2
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ASCO Annual Meeting
7. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at AUA Annual Meeting
8. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
9. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
Post Your Comments:
(Date:5/23/2013)... 23, 2013 EarlySense, the market ... the prize for ,Best Novel Idea, at the 8 ... Teams International Conference, hosted this year in the UK ... a clinical research team studying the impact of the ... Los Angeles . The prize was ...
(Date:5/23/2013)...  MedVantx, Inc., the company that has pioneered a ... the Company has completed a major expansion of its ... and the upgrade of its systems to offer a ... specialty home delivery pharmacy in Sioux Falls, ... physicians, health systems and payors novel distribution services, as ...
(Date:5/23/2013)... NEW YORK , May 23, 2013  Echo ... has committed to waive down the Acceptance Threshold from ... Affected plus one Elan Share in accordance with the ... to the conditions summarized below. Under the ... to acquire Elan (NYSE: ELN ) for ...
Breaking Medicine Technology:Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 2Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 3Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 4MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10
... , NEW YORK, ... research report is available in its catalogue: , ... 2009 (15 Countries) , http://www.reportlinker.com/p0166835/European-Markets-for-Drug-Eluting-and-Bare-Metal-Stents-2009-15-Countries.html ... encompasses Germany, France, the United Kingdom (U.K.), Italy, Spain, ...
... , NEW YORK, Dec. ... report is available in its catalogue: , Radiopharmaceuticals ... http://www.reportlinker.com/p0164273/Radiopharmaceuticals---A-US-and-European-Market-Analysis.html , The market for radiopharmaceuticals continues ... acceptance and utilization of nuclear medicine equipment, as well ...
Cached Medicine Technology:Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 2Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 3Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 4Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 5Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 6Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 7Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 2Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 3Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 4Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 5Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 6Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 7Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 8Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 9Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 10
(Date:5/23/2013)... In his pulse-quickening novel, “The AIDS Covenant” (published ... trust your government?” , In the “The AIDS Covenant,” readers ... London ’s Heathrow Airport. His American colleague, Alan Milner ... him to arrive at his Sierra Nevada ski-lodge. ... doubts about the government’s report. When Alan learns that Owen ...
(Date:5/23/2013)... CT (PRWEB) May 23, 2013 ... satisfaction and perception management tools, and ASCA, the ... develop the new ASCA Benchmarking Program. Voyance ... surveying technology and national benchmarking experience to support ... a comprehensive, state-of-the-art benchmarking tool. , “Voyance is ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Funeral Financials ... Memorial Day to the EOD Memorial Foundation ... be the greatest victims from the war. , ... originated in 1941 before the U.S. was even at ... Forces are identified with the Explosive Ordnance Disposal Badge. ...
(Date:5/23/2013)... By Denise Mann HealthDay Reporter , , THURSDAY, ... of Americans take to help treat hip and knee ... increase risk for developing glaucoma, a small new study ... there is an increase of intraocular pressure (IOP) or ... of the leading causes of blindness. ...
(Date:5/23/2013)... when a woman harried by hot flashes says she,s ... published online in Menopause , the journal of ... objective tests that what these women say about their ... showed that hot flashes were related to memory problems, ... there was a relationship between hot flashes and what ...
Breaking Medicine News(10 mins):Health News:New Book “The AIDS Covenant” by Roy Harris Delivers Intriguing, Captivating Story 2Health News:Voyance and ASCA Announce Strategic Partnership to Better the ASC Industry 2Health News:Voyance and ASCA Announce Strategic Partnership to Better the ASC Industry 3Health News:Funeral Financials Asks Americans to Donate their Memorial Day Beer Money to Help EOD Scholarship 2Health News:Funeral Financials Asks Americans to Donate their Memorial Day Beer Money to Help EOD Scholarship 3Health News:Glucosamine Supplements Tied to Risk of Eye Condition 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 3
... Reporter , TUESDAY, Jan. 18 (HealthDay News) -- Preliminary ... treatment for multiple sclerosis can help relieve fatigue and ... of the claims. The debate started in 2009, ... published an intriguing study that suggested that a blockage ...
... News) -- In a study finding that may not ... strong negative impact on how long it takes someone to ... Researchers recruited more than 5,000 Australian twins in the early ... which some became alcohol-dependent. The study also looked at the ...
... at Rochester Institute of Technology indicates that the incidence ... is more than 25 percent higher among deaf and ... shows a direct correlation between childhood maltreatment and higher ... adulthood. The study, which was presented at the ...
... (HealthDay News) -- Kidneys from live donors that are transported ... use in transplants as a kidney from a donor in ... Researchers followed up on 56 kidneys from live donors ... States and Canada. All of the transplanted organs survived and ...
... Maintaining periodontal health may contribute to a healthy ... Journal of Periodontology . A new study suggests that ... such as chronic obstructive pulmonary disease (COPD) and pneumonia. ... upper throat are inhaled into the lower respiratory tract, ...
... has been issued a US patent claiming a method ... their surfaces. The method, discovered by John Cambier, PhD, ... Jewish Health, holds promise for treatment of B-cell mediated ... and rejection of organ transplants. This therapeutic approach has ...
Cached Medicine News:Health News:Vein-Opening Treatment for MS Stirs Controversy 2Health News:Vein-Opening Treatment for MS Stirs Controversy 3Health News:Vein-Opening Treatment for MS Stirs Controversy 4Health News:Study: Abuse rates higher among deaf and hard-of-hearing children compared with hearing youths 2Health News:Donor Kidneys Travel Safely, Study Finds 2Health News:Healthy gums may lead to healthy lungs 2Health News:Patent awarded for method to dampen immune response 2
... pipette management software enables you to ... assurance program. Use Pipette Tracker to ... automatically log data from PCS, set ... and create custom management and compliance ...
... the Jarvik 2000 pump is about the size ... shell sits a direct-current motor, a rotor supported ... part: a small, spinning titanium impeller that pumps ... liters per minute. Rather than take over for ...
... The InVance Male Sling System is ... for mild to moderate stress urinary incontinence ... a solution for men who are not ... to limited manual dexterity, limited mental capacity ...
... third generation cardiac assist system primarily designed as ... suffering heart failure., ,It is a blood pump ... diseased heart to help the ailing hearts pumping ... of life. , ,It can also be used ...
Medicine Products: